Axsome Therapeutics' SWOT analysis: stock poised for growth amid CNS breakthroughs
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company has been gaining significant ...
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Nurix Therapeutics (NRIX) and Merit Medical Systems (MMSI)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Axsome Therapeutics (AXSM – Research ...
RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...
William Blair Reiterates “Outperform” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at ...
What is HC Wainwright’s Estimate for AXSM FY2024 Earnings?
HC Wainwright upped their FY2024 earnings estimates for Axsome Therapeutics in a research note issued to investors on Tuesday ...
Zacks.com on MSN6d
Axsome Shares Rise 19% in a Month: What's Driving the Rally?
AXSM stock is riding on upbeat preliminary 2024 results. The company's depression drug, Auvelity, drives its top line while ...
Seeking Alpha3d
AXSM Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company’s commercial ...
Yahoo Finance2d
Axsome Therapeutics, Inc. (AXSM)
After hours: 7:00:15 p.m. EST ...